Published in Philos Trans R Soc Lond B Biol Sci on June 29, 2007
TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res (2012) 1.39
Harnessing the wealth of Chinese scientific literature: schistosomiasis research and control in China. Emerg Themes Epidemiol (2008) 1.05
How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials? Malar J (2011) 0.96
A comparison of the cytotoxic potential of standardized aqueous and ethanolic extracts of a polyherbal mixture comprised of Nigella sativa (seeds), Hemidesmus indicus (roots) and Smilax glabra (rhizome). Pharmacognosy Res (2010) 0.94
Data-mining of potential antitubercular activities from molecular ingredients of traditional Chinese medicines. PeerJ (2014) 0.80
The globalization of traditional medicine in northern peru: from shamanism to molecules. Evid Based Complement Alternat Med (2013) 0.78
A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy. BMC Complement Altern Med (2016) 0.77
Novel small molecule modulators of plant growth and development identified by high-content screening with plant pollen. BMC Plant Biol (2016) 0.76
In vitro antioxidant, anti-inflammatory and anticancer activities of ethyl acetate soluble proanthocyanidins of the inflorescence of Cocos nucifera L. BMC Complement Altern Med (2016) 0.75
The quest for medicines, a grand challenge in the twenty-first century. Front Pharmacol (2010) 0.75
Qinghaosu (artemisinin): an antimalarial drug from China. Science (1985) 4.95
Multicomponent therapeutics for networked systems. Nat Rev Drug Discov (2005) 3.99
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med (2004) 3.92
High-throughput and ultra-high-throughput screening: solution- and cell-based approaches. Curr Opin Biotechnol (2000) 1.71
Arteether, a new antimalarial drug: synthesis and antimalarial properties. J Med Chem (1988) 1.69
Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp Parasitol (1985) 1.46
Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci (2001) 1.43
A new integrated program for natural product development and the value of an ethnomedical approach. J Altern Complement Med (2001) 1.41
Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther (2000) 1.37
Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop (2002) 1.36
Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet (2000) 1.33
Current status of artemisinin and its derivatives as antimalarial drugs. Life Sci (2000) 1.26
The potential of artemether for the control of schistosomiasis. Int J Parasitol (2001) 1.24
Medicines from nature: are natural products still relevant to drug discovery? Trends Pharmacol Sci (1999) 1.23
The detoxification enzyme systems. Altern Med Rev (1998) 1.23
Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun (1982) 1.20
Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle. Bioorg Med Chem Lett (2001) 1.08
Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine (2002) 1.05
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J Cancer Res Clin Oncol (2004) 1.02
Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res (2003) 1.01
High-throughput screening: advances in assay technologies. Curr Opin Chem Biol (1997) 0.97
Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci (2004) 0.97
Retinoic acid and arsenic for treating acute promyelocytic leukemia. PLoS Med (2005) 0.97
Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin Cardiol (1988) 0.97
Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J Ethnopharmacol (1997) 0.96
Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci (1993) 0.95
Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med (1999) 0.95
Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology (2000) 0.94
Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells. Int J Cancer (2003) 0.93
Protective effect of danshen during myocardial ischemia and reperfusion: an isolated rat heart study. Am J Chin Med (1990) 0.90
Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol. World J Gastroenterol (2004) 0.89
Ham-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosis. Hematology Am Soc Hematol Educ Program (2003) 0.88
Natural PTP1B inhibitors from Broussonetia papyrifera. Bioorg Med Chem Lett (2002) 0.86
Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B. Acta Pharmacol Sin (2000) 0.85
Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron (1992) 0.84
Natural product source material use in the pharmaceutical industry: the Glaxo experience. J Ethnopharmacol (1996) 0.84
Rediscovering natural product biodiversity. Drug Discov Today (1999) 0.84
The chemical-biological interface: developments in automated and miniaturised screening technology. Curr Opin Biotechnol (1997) 0.84
Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. Bioorg Med Chem Lett (2000) 0.83
Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am J Chin Med (1999) 0.82
Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae Radix in the rat. Gen Pharmacol (1994) 0.82
In vitro cytotoxicity of salvicine, a novel diterpenoid quinone. Zhongguo Yao Li Xue Bao (1999) 0.81
Transmission electron microscopic observations on ultrastructural damage in juvenile Schistosoma mansoni caused by artemether. Acta Trop (2002) 0.81
Biochemical effects of berberine. Biochem Pharmacol (1979) 0.80
DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells. Cancer Chemother Pharmacol (2004) 0.80
Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis. Biochem Pharmacol (2001) 0.79
Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs (2001) 0.79
Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study. World J Gastroenterol (2005) 0.78
Synthesis and antitumour activity of novel diterpenequinone salvicine and the analogs. Bioorg Med Chem Lett (1999) 0.78
Study of Costus lucanusianus: plant juice, fraction combinations and pharmacologic estimation of natural product total activity. J Ethnopharmacol (1991) 0.78
Screensavers: trends in high-throughput analysis. Trends Biotechnol (1999) 0.77
[Inhibition of magnesium lithospermate B on the c-Jun N-terminal kinase 3 mRNA expression in cardiomyocytes encountered ischemia/reperfusion injury]. Yao Xue Xue Bao (2003) 0.77
DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae. Acta Pharmacol Sin (2001) 0.77
Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells. Biochem Biophys Res Commun (2004) 0.77
Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Acta Pharmacol Sin (2000) 0.77
A 3D-QSAR study on ginkgolides and their analogues with comparative molecular field analysis. Bioorg Med Chem Lett (1998) 0.77
Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem Pharmacol (2002) 0.77
[Study on the metabolites of guanfu base A hydrochloride in rat urine by high performance liquid chromatograph-mass spectrum]. Yao Xue Xue Bao (2002) 0.76
Identification of phase I and phase II metabolites of Guanfu base A hydrochloride in human urine. Eur J Drug Metab Pharmacokinet (2004) 0.76
Predicting protein-protein interactions based only on sequences information. Proc Natl Acad Sci U S A (2007) 3.06
PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics (2008) 2.35
TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res (2006) 2.26
A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice. Proc Natl Acad Sci U S A (2007) 1.43
Gossypol induces Bax/Bak-independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2. FASEB J (2006) 1.40
Conformational transition of amyloid beta-peptide. Proc Natl Acad Sci U S A (2005) 1.28
A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis. Cell Res (2011) 1.27
Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation. Protein Sci (2006) 1.25
Virtual screening on natural products for discovering active compounds and target information. Curr Med Chem (2003) 1.25
Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells. Mol Cancer Ther (2008) 1.22
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol (2005) 1.15
Structural basis for catalytic and inhibitory mechanisms of beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ). J Biol Chem (2007) 1.11
pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J Mol Biol (2005) 1.09
Conformational dynamics of the nicotinic acetylcholine receptor channel: a 35-ns molecular dynamics simulation study. J Am Chem Soc (2005) 1.07
Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation. Protein Sci (2005) 1.06
Malonyl-CoA: acyl carrier protein transacylase from Helicobacter pylori: Crystal structure and its interaction with acyl carrier protein. Protein Sci (2007) 1.04
Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun (2004) 1.03
Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channels. J Mol Biol (2002) 1.02
Detailed mechanism for AmtB conducting NH4+/NH3: molecular dynamics simulations. Biophys J (2006) 1.02
Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels. Biophys J (2002) 1.00
GAsDock: a new approach for rapid flexible docking based on an improved multi-population genetic algorithm. Bioorg Med Chem Lett (2004) 1.00
Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori. FEBS J (2006) 0.98
Spiro[pyrrolidine-2,3'-oxindole] derivatives synthesized by novel regionselective 1,3-dipolar cycloadditions. Mol Divers (2011) 0.97
Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor. Biophys J (2003) 0.97
Conformational transition pathway in the allosteric process of human glucokinase. Proc Natl Acad Sci U S A (2006) 0.97
Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT. Biophys J (2003) 0.97
How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations. J Am Chem Soc (2003) 0.96
Binding analyses between Human PPARgamma-LBD and ligands. Eur J Biochem (2004) 0.95
Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling. Bioorg Med Chem Lett (2007) 0.95
Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies. Clin Cancer Res (2011) 0.94
Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger. Fitoterapia (2012) 0.94
Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization. Biochemistry (2006) 0.92
A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity. J Med Chem (2010) 0.91
Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation. J Phys Chem B (2005) 0.91
Seco-pregnane steroids target the subgenomic RNA of alphavirus-like RNA viruses. Proc Natl Acad Sci U S A (2007) 0.91
Cinnamtannin D-1 protects pancreatic β-cells from palmitic acid-induced apoptosis by attenuating oxidative stress. J Agric Food Chem (2014) 0.90
3-Acetonyl-3-hydroxyoxindole: a new inducer of systemic acquired resistance in plants. Plant Biotechnol J (2008) 0.90
Discovering potassium channel blockers from synthetic compound database by using structure-based virtual screening in conjunction with electrophysiological assay. J Med Chem (2007) 0.90
Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule. J Biol Chem (2011) 0.90
A simple and convenient copper-catalyzed tandem synthesis of quinoline-2-carboxylates at room temperature. J Org Chem (2009) 0.90
Dynamic mechanism for the autophosphorylation of CheA histidine kinase: molecular dynamics simulations. J Am Chem Soc (2005) 0.89
Effect of total phenolics from Laggera alata on acute and chronic inflammation models. J Ethnopharmacol (2006) 0.89
SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization. Biochemistry (2005) 0.89
Characterization and inhibitor discovery of one novel malonyl-CoA: acyl carrier protein transacylase (MCAT) from Helicobacter pylori. FEBS Lett (2006) 0.89
The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. FEBS Lett (2005) 0.89
Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors. J Med Chem (2010) 0.89
QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR. J Comput Aided Mol Des (2006) 0.89
Exploring transition pathway and free-energy profile of large-scale protein conformational change by combining normal mode analysis and umbrella sampling molecular dynamics. J Phys Chem B (2013) 0.88
Molecular basis of NDM-1, a new antibiotic resistance determinant. PLoS One (2011) 0.88
Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide. Biochemistry (2006) 0.88
Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors. J Med Chem (2011) 0.88
Severe acute respiratory syndrome coronavirus membrane protein interacts with nucleocapsid protein mostly through their carboxyl termini by electrostatic attraction. Int J Biochem Cell Biol (2005) 0.88
Influence of the water molecule on cation-pi interaction: ab initio second order Møller-Plesset perturbation theory (MP2) calculations. J Phys Chem B (2005) 0.87
Novel anti-Alzheimer's dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets. Neurotherapeutics (2009) 0.87
Halogen bond: its role beyond drug-target binding affinity for drug discovery and development. J Chem Inf Model (2014) 0.87
Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFbeta/Smad2 signaling. Chembiochem (2007) 0.87
Fluorogenic probing of specific recognitions between sugar ligands and glycoprotein receptors on cancer cells by an economic graphene nanocomposite. Adv Mater (2013) 0.86
Antimicrobial activity of globulol isolated from the fruits of Eucalyptus globulus Labill. Nat Prod Res (2008) 0.86
Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase. Mol Pharmacol (2007) 0.86
Efficient copper-promoted N-arylations of aryl halides with amines. J Comb Chem (2008) 0.86
Small-molecule modulation of Wnt signaling via modulating the Axin-LRP5/6 interaction. Nat Chem Biol (2013) 0.85
Diverse mechanisms of antidiabetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice. J Agric Food Chem (2012) 0.85
Estimation of carcinogenicity using molecular fragments tree. J Chem Inf Model (2012) 0.85
One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation. Bioorg Med Chem (2006) 0.85
Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays. J Virol (2008) 0.84
Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation. J Biochem (2006) 0.84
Capturing intercellular sugar-mediated ligand-receptor recognitions via a simple yet highly biospecific interfacial system. Sci Rep (2013) 0.84
Combinatorial pharmacophore modeling of organic cation transporter 2 (OCT2) inhibitors: insights into multiple inhibitory mechanisms. Mol Pharm (2013) 0.84
Blocking of the nicotinic acetylcholine receptor ion channel by chlorpromazine, a noncompetitive inhibitor: A molecular dynamics simulation study. J Phys Chem B (2006) 0.84
Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genomics Proteomics (2010) 0.84
Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A. J Med Chem (2002) 0.84
Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int J Pharm (2009) 0.83
Alkaloid polymorphism and ITS sequence variation in the Spiraea japonica complex (Rosaceae) in China: traces of the biological effects of the Himalaya-Tibet Plateau uplift. Am J Bot (2006) 0.83
Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1. J Inorg Biochem (2009) 0.83
Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations. Biophys J (2007) 0.83
Mutagenic probability estimation of chemical compounds by a novel molecular electrophilicity vector and support vector machine. Bioinformatics (2006) 0.83
Elucidating the inhibiting mode of AHPBA derivatives against HIV-1 protease and building predictive 3D-QSAR models. J Med Chem (2002) 0.83
Tackling reactivity and selectivity within a strained architecture: construction of the [6-6-5-7] tetracyclic core of Calyciphylline alkaloids. J Org Chem (2012) 0.82
Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile. Bioorg Med Chem (2012) 0.82
Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis. J Biochem (2008) 0.82
Amide N-glycosylation by Asm25, an N-glycosyltransferase of ansamitocins. Chem Biol (2008) 0.82
Molecular insight into the interaction between IFABP and PA by using MM-PBSA and alanine scanning methods. J Phys Chem B (2007) 0.82
Lys169 of human glucokinase is a determinant for glucose phosphorylation: implication for the atomic mechanism of glucokinase catalysis. PLoS One (2009) 0.82
A new rapid and effective chemistry space filter in recognizing a druglike database. J Chem Inf Model (2005) 0.82
Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues. Bioorg Med Chem (2002) 0.81
Structure-based discovery of potassium channel blockers from natural products: virtual screening and electrophysiological assay testing. Chem Biol (2003) 0.81
Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor. Bioorg Med Chem (2004) 0.81
A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein. Arch Biochem Biophys (2009) 0.81
Molecular docking and 3D-QSAR studies on the binding mechanism of statine-based peptidomimetics with beta-secretase. Bioorg Med Chem (2005) 0.81
Efficient iron/copper cocatalyzed alkynylation of aryl iodides with terminal alkynes. J Org Chem (2008) 0.81
Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus. Protein Expr Purif (2003) 0.81
Identification and synthesis of N'-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase. Bioorg Med Chem Lett (2011) 0.81
A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide. Anal Biochem (2009) 0.81
A knowledge-based halogen bonding scoring function for predicting protein-ligand interactions. J Mol Model (2013) 0.81
Molecular dynamics simulations on the mechanism of transporting methylamine and ammonia by ammonium transporter AmtB. J Phys Chem B (2010) 0.80
Flavone and isoflavone derivatives of terrestrial plants as larval settlement inhibitors of the barnacle Balanus amphitrite. Biofouling (2009) 0.80
Cell-permeable iminocoumarine-based fluorescent dyes for mitochondria. Org Lett (2011) 0.80
Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score. J Comb Chem (2005) 0.80